Results 1 to 10 of about 20,763 (194)

Prognosis Following Surgery for Recurrent Ovarian Cancer and Diagnostic Criteria Predictive of Cytoreduction Success: A Systematic Review and Meta-Analysis [PDF]

Diagnostics, 2023
For women achieving clinical remission after the completion of initial treatment for epithelial ovarian cancer, 80% with advanced-stage disease will develop recurrence.
Faiza Gaba, Oleg Blyuss, Dhivya Chandrasekaran, Nicolò Bizzarri, Basel Refky, Desmond Barton, Thomas Ind, Marielle Nobbenhuis, John Butler, Owen Heath, Arjun Jeyarajah, Elly Brockbank, Alexandra Lawrence, Ranjit Manchanda, James Dilley, Saurabh Phadnis, on behalf of the GO SOAR Collaborative   +16 more
doaj   +6 more sources

Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively? [PDF]

World Journal of Surgical Oncology, 2010
Introduction Prediction of optimal cytoreduction in patients with advanced epithelial ovarian caner preoperatively. Methods Patients with advanced epithelial ovarian cancer who underwent surgery for the first time from Jan.
Behtash Nadereh, Ghaemmaghami Fatemeh, Guilani Mitra, Mazhari Marjan, Mousavi Azam-Sadat, Akhavan Setareh   +5 more
doaj   +5 more sources

The correlation between the extent of left upper abdominal resections and perioperative outcomes in advanced stage and relapsed ovarian cancer [PDF]

Romanian Journal of Medical Practice, 2020
The aim of this study is to analyze the feasibility and safety of left upper abdominal resections as part of debulking surgery. Case series presentation. Between January 2015 and August 2019, 32 patients were submitted to left upper abdominal resections.
Nicolae BACALBASA, Irina BALESCU, Camelia DIACONU, Simona DIMA, Laura ILIESCU, Mihai DIMITRIU, Mihaela VILCU, Alexandru FILIPESCU, Ioana HALMACIU, Dragos CRETOIU, Iulian BREZEAN   +10 more
doaj   +1 more source

The role of quaternary cytoreduction in relapsed ovarian cancer – a systematic review [PDF]

Archives of the Balkan Medical Union, 2020
Introduction. Ovarian cancer is characterized by a high capacity of relapse, even in cases in whom cytoreductive surgery with curative intent followed by platinum and taxanes-based chemotherapy were performed.
Nicolae BACALBASA, Irina BALESCU, Mihaela VILCU, Ioana HALMACIU, Camelia C. DIACONU, Simona DIMA, Iulian BREZEAN   +6 more
doaj   +1 more source

A Cohort Study to Decode the Application of Peritoneal Carcinomatosis Index in Predicting the Prognosis of Advanced Ovarian Malignancies [PDF]

Journal of Clinical and Diagnostic Research, 2022
Introduction: Peritoneal Carcinomatosis Index (PCI) is used to assess the extent of peritoneal cancer by dividing the peritoneal cavity into 13 well-defined regions and assessing the size of the largest tumour nodule in each region. Aim: To evaluate the
Athul Damodaran, Gopinathan Kathirvelu, Devimeenal Jagannathan   +2 more
doaj   +1 more source

The application of pringle manoeuvre, type three liver mobilisation, full thickness diaphragmatic resection with primary closure technique and peritonectomy in the management of advanced ovarian malignancy [PDF]

Obstetrics & Gynecology Science, 2023
Objective We present an educational technique for the safe completion of complete cytoreduction of diaphragmatic disease for the management of advanced ovarian malignancy.
Sarah Louise Smyth, Hooman Soleymani Majd   +1 more
doaj   +1 more source

Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer [PDF]

Obstetrics & Gynecology Science, 2020
ObjectiveEpithelial ovarian cancer (EOC) requires an aggressive surgical approach. The important part of literature on ovarian cancer surgery emphasize residual tumor and survival analyses. Morbidity issue keeps in background.
Emre Günakan, Yusuf Aytaç Tohma, Mehmet Tunç, Hüseyin Akıllı, Hanifi Şahin, Ali Ayhan   +5 more
doaj   +1 more source

Developing a Novel Image Marker to Predict the Clinical Outcome of Neoadjuvant Chemotherapy (NACT) for Ovarian Cancer Patients [PDF]

Computers in Biology and Medicine 172 (2024): 108240, 2023
Objective Neoadjuvant chemotherapy (NACT) is one kind of treatment for advanced stage ovarian cancer patients. However, due to the nature of tumor heterogeneity, the clinical outcomes to NACT vary significantly among different subgroups. Partial responses to NACT may lead to suboptimal debulking surgery, which will result in adverse prognosis.
arxiv   +1 more source

Ovarian cancer: Is an expert surgical oncologist mandatory? [PDF]

Journal of Clinical and Investigative Surgery, 2019
Ovarian cancer has the worst prognosis of all gynecologic malignancies. The standard treatment of patients with ovarian cancer is a multidisciplinary assignment involving aggressive surgery with or without chemotherapy.
Montassar Ghaleb, Hanen Bouaziz, Sarah Sghaier, Maher Slimane, Hatem Bouzaiene, Jamel Ben Hassouna, Tarek Ben Dhiab, Monia Hechiche, Riadh Chargui, Khaled Rahal   +9 more
doaj   +1 more source

BEV-IP : perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis [PDF]

, 2015
Background: Selected patients with peritoneal carcinomatosis (PC) from colorectal cancer (CRC) benefit from cytoreductive surgery (CRS) combined with intraperitoneal chemoperfusion (IPC).
Ceelen, Wim, Liberale, Gabriel, Van Der Speeten, Kurt, Willaert, Wouter   +3 more
core   +4 more sources